Download presentation
Presentation is loading. Please wait.
Published byJaroslav Štěpánek Modified over 5 years ago
1
A randomized trial of methotrexate versus azathioprine for severe atopic eczema
Mandy Elvira Schram, MD, Evelien Roekevisch, MD, Mariska Maria Geertruida Leeflang, PhD, Jan Dositheus Bos, MD, PhD, FRCP, Jochen Schmitt, MD, Phyllis Ira Spuls, MD, PhD Journal of Allergy and Clinical Immunology Volume 128, Issue 2, Pages (August 2011) DOI: /j.jaci Copyright © 2011 American Academy of Allergy, Asthma & Immunology Terms and Conditions
2
Fig 1 Screening, randomization, treatment, and follow-up of study participants. ∗Data for the per-protocol analysis are not shown. AE, Adverse event. Journal of Allergy and Clinical Immunology , DOI: ( /j.jaci ) Copyright © 2011 American Academy of Allergy, Asthma & Immunology Terms and Conditions
3
Fig 2 Mean (SD) scores for the SCORAD score at baseline, during treatment, and during follow-up. AZA, Azathioprine; MTX, methotrexate. Journal of Allergy and Clinical Immunology , DOI: ( /j.jaci ) Copyright © 2011 American Academy of Allergy, Asthma & Immunology Terms and Conditions
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.